Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections

Antimicrobial Resistance and Infection Control

Volumn 3, Issue 1, 2014, Pages

  Spadafino, Joseph T ^a   Cohen, Bevin ^a,b   Liu, Jianfang ^b   Larson, Elaine ^a,b  

^a Department of Medicine   (United States)

^b Columbia University School of Nursing ^*  (United States)

Author keywords

Antimicrobial resistance; Catheter associated urinary tract infections; Extended spectrum beta lactamase producing Escherichia coli

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLADDER CATHETERIZATION; CASE CONTROL STUDY; CATHETER ASSOCIATED URINARY TRACT INFECTION; CATHETER INFECTION; COMMUNITY HOSPITAL; ELECTRONIC HEALTH RECORD; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; NEW YORK; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREND STUDY; URINARY TRACT DISEASE; URINARY TRACT INFECTION; VERY ELDERLY;

EID: 84988851155     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/s13756-014-0039-y     Document Type: Article

References (10)

1. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK: NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
2. Ena J, Arjona F, Martinez-Peinado C, Lopez-Perezagua Mdel M, Amador C: Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 2006, 68:1169-1174.
3. Zilberberg MD, Shorr AF: Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Infect Control Hosp Epidemiol 2013, 34:940-946.
4. Apte M, Neidell M, Furuya EY, Caplan D, Glied S, Larson E: Using Electronically Available Inpatient Hospital Data for Research. Clin Transl Sci 2011, 4:338-345.
5. Landers T, Apte M, Hyman S, Furuya Y, Glied S, Larson E: A comparison of methods to detect urinary tract infections using electronic data. Jt Comm J Qual Patient Saf 2010, 36:411-417.
6. Azap OK, Arslan H, Serefhanoqlu K, Colakoglu S, Erdogan H, Timurkaynak F, Senger SS: Risk factors for extended-spectrum b-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 2010, 16:147-151.
7. Arslan H, Azap OK, Ergönül O, Colakoglu S, Erdogan H, Timurkaynak F, Senger SS: Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005, 56:914-918.
8. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J: Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum b-lactamases. J Antimicrob Chemother 2006, 57:780-783.
9. Yamamichi F, Shigemura K, Matsumoto M, Nakano Y, Tanaka K, Arakawa S, Fujisawa M: Relationship between Urinary Tract Infection Categorization and Pathogens' Antimicrobial Susceptibilities. Urol Int 2012, 88:198-208.
10. Briongos-Figuero LS, Gómez-Traveso T, Bachiller-Luque P, Domínguez-Gil González M, Gómez-Nieto A, Palacios-Martín T, González-Sagrado M, Dueñas-Laita A, Pérez-Castrillón JL: Epidemiology, risk factors, and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteria. Int J Clin Pract 2012, 66:891-896.